“…Different PCM mammalian (e.g., murine, rat, guinea pigs, hamsters, and rabbits) and nonmammalian models (e.g., amoebas, nematode Caenorhabditis elegans , and insect Galleria mellonella ) have been used to investigate distinct aspects of fungal infection and host–fungal interaction in a complex organism, such as fungal virulence, pathogenesis, immunological response, test pharmacological therapies, and find novel antimycotic compounds [ 13 , 16 , 17 , 18 ]. Albeit, the gold standard for in vivo studies still is the murine model of infection, and there are well-established models of PCM resistance (e.g., A/Sn or A/J murine strains) and susceptibility (e.g., B10.A, BIOD2/nSn, and BIOD2/oSn murine strains), both sharing high similarity to most common host responses observed in humans [ 19 , 20 , 21 , 22 , 23 , 24 , 25 ]. The B10.A, BIOD2/nSn, and BIOD2/oSn isogenic strains mimic the chronic, progressive, and disseminated forms of human PCM, whereas the A/Sn or A/J strains have similarities to the regressive or localized forms of infection [ 15 , 19 , 22 ].…”